Fibromuscular Dysplasia in an Adult Male As a Cause of Renal Artery Stenosis and Secondary Hypertension Treated with Renal Artery Stenting

Overview

Journal Egypt Heart J

Publisher Springer

Specialty Cardiology & Vascular Diseases

Date 2018 Apr 7

PMID 29622959

Citations 1

Authors

K C Bishal

Rabi Malla

Chandra Mani Adhikari

Binay Rauniyar

Deepak Limbu

Affiliations

Soon will be listed here.

Abstract

Background: Renovascular hypertension due to fibromuscular dysplasia is an uncommon cause of secondary hypertension and is more common in females. This entity is an important treatable cause of secondary hypertension.

Case Presentation: We report the case of a 21-year-old asymptomatic male found to have high blood pressure on routine checkup. Renal angiogram revealed fibromuscular dysplasia involving the right renal artery. He underwent percutaneous angioplasty with complete recovery. The single antihypertensive which he was on was stopped next month.

Conclusion: Fibromuscular dysplasia causing stenosis of renal artery is uncommon. High degree of suspicion is required for the timely diagnosis and treatment of this potentially treatable cause of secondary hypertension.

Citing Articles

Bilateral renal artery stenosis treated with drug-eluting balloon angioplasty in unique treatment.

Morosetti D, Chiocchi M, De Crescenzo F, DOnofrio A, Di Martino A, Raso A Radiol Case Rep. 2018; 14(2):242-245.

PMID: 30479680 PMC: 6250753. DOI: 10.1016/j.radcr.2018.10.033.

References

Radermacher J, Chavan A, Bleck J, Vitzthum A, STOESS B, Gebel M . Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med. 2001; 344(6):410-7. DOI: 10.1056/NEJM200102083440603. View

Chobanian A, Bakris G, Black H, Cushman W, Green L, Izzo Jr J . Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42(6):1206-52. DOI: 10.1161/01.HYP.0000107251.49515.c2. View

Tullis M, Caps M, Zierler R, Bergelin R, Polissar N, Davidson R . Blood pressure, antihypertensive medication, and atherosclerotic renal artery stenosis. Am J Kidney Dis. 1999; 33(4):675-81. DOI: 10.1016/s0272-6386(99)70218-0. View

Plouin P, Perdu J, La Batide-Alanore A, Boutouyrie P, Gimenez-Roqueplo A, Jeunemaitre X . Fibromuscular dysplasia. Orphanet J Rare Dis. 2007; 2:28. PMC: 1899482. DOI: 10.1186/1750-1172-2-28. View

KINCAID O, DAVIS G, HALLERMANN F, Hunt J . Fibromuscular dysplasia of the renal arteries. Arteriographic features, classification, and observations on natural history of the disease. Am J Roentgenol Radium Ther Nucl Med. 1968; 104(2):271-82. View

Weinberg I, Gu X, Giri J, Kim S, Bacharach M, Gray B . Anti-platelet and anti-hypertension medication use in patients with fibromuscular dysplasia: Results from the United States Registry for Fibromuscular Dysplasia. Vasc Med. 2015; 20(5):447-53. DOI: 10.1177/1358863X15584982. View

de Fraissinette B, Garcier J, Dieu V, Mofid R, Ravel A, Boire J . Percutaneous transluminal angioplasty of dysplastic stenoses of the renal artery: results on 70 adults. Cardiovasc Intervent Radiol. 2002; 26(1):46-51. DOI: 10.1007/s00270-002-1797-0. View

Sos T, Pickering T, Sniderman K, Saddekni S, Case D, Silane M . Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N Engl J Med. 1983; 309(5):274-9. DOI: 10.1056/NEJM198308043090504. View

Canavese C, Mereu M, Aime S, Lazzarich E, Fenoglio R, Quaglia M . Gadolinium-associated nephrogenic systemic fibrosis: the need for nephrologists' awareness. J Nephrol. 2008; 21(3):324-36. View

10.

Slovut D, Olin J . Fibromuscular dysplasia. N Engl J Med. 2004; 350(18):1862-71. DOI: 10.1056/NEJMra032393. View

11.

Deal J, Snell M, BARRATT T, Dillon M . Renovascular disease in childhood. J Pediatr. 1992; 121(3):378-84. DOI: 10.1016/s0022-3476(05)81789-5. View

12.

Lewin A, BLAUFOX M, CASTLE H, ENTWISLE G, Langford H . Apparent prevalence of curable hypertension in the Hypertension Detection and Follow-up Program. Arch Intern Med. 1985; 145(3):424-7. View

13.

Geavlete O, Calin C, Croitoru M, Lupescu I, Ginghina C . Fibromuscular dysplasia--a rare cause of renovascular hypertension. Case study and overview of the literature data. J Med Life. 2012; 5(3):316-20. PMC: 3465001. View

14.

Trinquart L, Mounier-Vehier C, Sapoval M, Gagnon N, Plouin P . Efficacy of revascularization for renal artery stenosis caused by fibromuscular dysplasia: a systematic review and meta-analysis. Hypertension. 2010; 56(3):525-32. DOI: 10.1161/HYPERTENSIONAHA.110.152918. View

15.

Safian R, Textor S . Renal-artery stenosis. N Engl J Med. 2001; 344(6):431-42. DOI: 10.1056/NEJM200102083440607. View

16.

Urban B, Ratner L, Fishman E . Three-dimensional volume-rendered CT angiography of the renal arteries and veins: normal anatomy, variants, and clinical applications. Radiographics. 2001; 21(2):373-86; questionnaire 549-55. DOI: 10.1148/radiographics.21.2.g01mr19373. View

17.

Textor S, Lerman L . Renovascular hypertension and ischemic nephropathy. Am J Hypertens. 2010; 23(11):1159-69. PMC: 3078640. DOI: 10.1038/ajh.2010.174. View

18.

Olin J, Gornik H, Bacharach J, Biller J, Fine L, Gray B . Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association. Circulation. 2014; 129(9):1048-78. DOI: 10.1161/01.cir.0000442577.96802.8c. View

19.

Begelman S, Olin J . Fibromuscular dysplasia. Curr Opin Rheumatol. 2000; 12(1):41-7. DOI: 10.1097/00002281-200001000-00007. View

20.

Dworkin L, Cooper C . Clinical practice. Renal-artery stenosis. N Engl J Med. 2009; 361(20):1972-8. PMC: 4812436. DOI: 10.1056/NEJMcp0809200. View